Qiagen NV | QIA - Gross Profit On Sales

Stock Price
41.96
Daily Change
0.57 1.38%
Monthly
-6.16%
Yearly
13.93%
Q1 Forecast
40.37

Qiagen NV reported $325.27M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 49.21M 13.25M Mar/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
argenx SE USD 1.14B 118.49M Dec/2025
Avita Medical AUD 14.95M 1.18M Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Moderna USD 226M 583M Dec/2025
Organon & Co USD 854M 3M Dec/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.15B 223.6M Dec/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025